Park Ha Biological Technology is trading $2.89 (+11.58%) amid stronger biotechnology sentiment, with biotech ETF XBI up 2.06%.

  • The stock is rebounding after falling 10.07% to $2.59 on August 25.
  • No fresh company-specific announcement dated August 26 was identified; earlier financing, reverse-split, and lawsuit-related reports do not clearly explain the move.